Login / Signup

First clinical experience with the new Surpass Evolve flow diverter: technical and clinical considerations.

Emanuele OrrùHenry RiceLaetitia De VilliersJesse M KlostranecAjay K WakhlooAlexander L CoonIvan RadovanovicHans KortmanKartik Dev BhatiaTimo KringsVitor M Pereira
Published in: Journal of neurointerventional surgery (2020)
Preliminary experience in patients demonstrates a good performance of the SE. This newly designed implant maintains the engineering characteristics of Surpass flow diverters, including precise placement due to its lower foreshortening and a high mesh density, yet can be deployed through a significantly lower-profile delivery system.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • patient reported